All In Biotech

Drug Trial Radar · NCT06174766

A Study to Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension Patients

A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate Efficacy and Safety of HGP2304 in Patients With Essential Hypertension

Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 356 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

356

Actual

Start

May 10, 2024

Primary completion

Jan 8, 2026

Study completion Jan 8, 2026

Sponsor

Sponsor type
Industry
First posted
Dec 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multicenter, randomized, double-blind, phase III study to evaluate efficacy and safety of HGP2304 in patients with essential hypertension

Conditions

  • Hypertension

Interventions

  • HGP2304-1Drug

    Test drug

  • HGP2304-2Drug

    Test drug

  • RLD2209-1Drug

    Control drug

  • RLD2209-2Drug

    Control drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in 24 hours ambulatory systolic blood pressureTime frame: baseline, 10 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Severance hosptal

    Seodaemun-gu, Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.